Neither you, nor anyone of us, knows that. It depends on results and the ability of management's negotiating skills.
Like all biotech's, study results are not guaranteed, which is why publicly traded companies must declare the forward looking statement clause from the 1930's.
In reply to:
you are talking a multiple of 10 times current share price on any deal.....imo